Product Information
TIMOLOL MALEATE 0.5% EYE DROP is a generic product labeled by Armas Pharmaceuticals Inc., priced at $1.2411 per EA under NDC 72485060260. Its NADAC has been published 157 times since Aug 9, 2023.
FDA first approved this application on May 8, 2023. Its Orange Book therapeutic-equivalence code is AT3.
Strength
6.8 mg/mL
Manufacturer
Armas Pharmaceuticals Inc.NDC
72485060260
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
7/22/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA217195FDA Approved
5/8/2023
TE Code
AT3
On Market Since
5/8/2023
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROP has been published 157 times since Aug 9, 2023, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2411 per EA |
|---|---|
| All-time high | $3.7766 (Jan 10, 2024) |
| All-time low | $1.2411 (Jul 22, 2026) |
| 52-week high | $2.2892 |
| 52-week low | $1.2411 |
| Median price | $2.2892 |
| Average price | $2.2487 |
| Largest weekly change | -49.1% (Jan 17, 2024) |
| Weeks tracked | 157 |
| Tracking since | Aug 9, 2023 |
1W
N/A
1M
N/A
3M
-9.8%
6M
-25.9%
1Y
-45.8%
3Y
-60.3%
5Y
N/A
All
-51.5%
Last surveyed Aug 5, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Armas Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROP, manufactured by Armas Pharmaceuticals Inc., is $1.2411 per EA (NDC 72485060260), effective Aug 5, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has declined 51.5%. It has been tracked across 157 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROP?
Since Aug 9, 2023, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has ranged from a low of $1.2411 (Jul 22, 2026) to a high of $3.7766 (Jan 10, 2024), with a median of $2.2892 per EA.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of TIMOLOL MALEATE 0.5% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROP?
TIMOLOL MALEATE 0.5% EYE DROP (NDC 72485060260) is labeled by Armas Pharmaceuticals Inc., and CMS classifies it as a generic product.